Incidence and Estimated Vaccine Effectiveness Against Hospitalizations for All-Cause Pneumonia Among Older US Adults Who Were Vaccinated and Not Vaccinated With 13-Valent Pneumococcal Conjugate Vaccine-Reference-Cited by-同舟云学术

Incidence and Estimated Vaccine Effectiveness Against Hospitalizations for All-Cause Pneumonia Among Older US Adults Who Were Vaccinated and Not Vaccinated With 13-Valent Pneumococcal Conjugate Vaccine

Published:2022-03-18 Issue:3 Volume:5 Page:e221111
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Hsiao Amber¹,Hansen John¹,Timbol Julius¹,Lewis Ned¹,Isturiz Raul²,Alexander-Parrish Ronika²,McLaughlin John M.²,Gessner Bradford D.²,Klein Nicola P.¹

Affiliation:

1. Kaiser Permanente Vaccine Study Center, Oakland, California

2. Pfizer Vaccine Medicines Development and Scientific Clinical Affairs, Collegeville, Pennsylvania

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2790262/hsiao_2022_oi_220062_1647021155.19805.pdf

Reference56 articles.

1. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged =65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP).;Tomczyk;MMWR Morb Mortal Wkly Rep,2014

2. A new pneumococcal capsule type, 10d, is the 100th serotype and has a large cps fragment from an oral streptococcus.;Ganaie;mBio,2020

3. New pneumococcal serotype 15D.;Pimenta;J Clin Micro,2021

4. Pediatric invasive pneumococcal disease in the United States in the era of pneumococcal conjugate vaccines.;Tan;Clin Microbiol Rev,2012

5. Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction—eight states, 1998-2005.;Centers for Disease Control and Prevention (CDC);MMWR Morb Mortal Wkly Rep,2008

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes and Hospital Service Use Among Patients With COPD in a Nurse- and Allied Health–Led Clinic;JAMA Health Forum;2024-07-05

2. Protective Effects from Prior Pneumococcal Vaccination in Patients with Chronic Airway Diseases during Hospitalization for Influenza—A Territory-Wide Study;Vaccines;2024-06-23

3. Human monoclonal antibodies protect against viral-mediated pneumococcal superinfection;Frontiers in Immunology;2024-06-12

4. Clinical and economic burden of invasive pneumococcal disease and noninvasive all-cause pneumonia in hospitalized US adults: A multicenter analysis from 2015 to 2020;International Journal of Infectious Diseases;2024-06

5. Pneumococcal vaccination effectiveness (PCV13 and PPSV23) in individuals with and without reduced kidney function: a test-negative design study;Clinical Kidney Journal;2024-05-08